Back to CITADEL ADVISORS LLC

ORMP
7 quarters

Position history for CITADEL ADVISORS LLC's holdings in ORAMED PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 98,629 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $335,338 as of 2026-Q1. The position was decreased (-49.7% shares). ORMP represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$335,338

Current Shares

98,629

Total Value Change

+$283,117

Total Shares Change

+77,227

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
98,629
-49.7%
$335,3380.0%$3.38
0
2025-Q4
Increased
196,020
+75.5%
$558,6570.0%$2.62
37
2025-Q3
Increased
111,707
+27.9%
$294,9060.0%$2.52
20
2025-Q2
Increased
87,316
+2645x
$196,4610.0%$2.00
25
2025-Q1
Decreased
33
-100.0%
$710.0%$2.06
0
2024-Q4
Increased
72,489
+238.7%
$175,4240.0%$2.17
25
2024-Q3
New
21,402
-
$52,2210.0%$2.31
32

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, MERCER GLOBAL ADVISORS INC /ADV, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used